Published by: Kowsar

Histopathological Distribution of Ovarian Masses Occurring After Hysterectomy: A Five-Year Assay in Iranian Patients

Afsaneh Lalooei 1 , Seyedeh Razieh Hashemi 1 and Mohammad Hossein Khosravi 2 , *
Authors Information
1 Obstetrics and Gynecology Department, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
2 Students’ Research Committee, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
Article information
  • Thrita: March 01, 2016, 5 (1); e33131
  • Published Online: January 30, 2016
  • Article Type: Brief Report
  • Received: September 13, 2015
  • Revised: October 14, 2015
  • Accepted: October 30, 2015
  • DOI: 10.5812/thrita.33131

To Cite: Lalooei A, Hashemi S R, Khosravi M H. Histopathological Distribution of Ovarian Masses Occurring After Hysterectomy: A Five-Year Assay in Iranian Patients, Thrita. 2016 ;5(1):e33131. doi: 10.5812/thrita.33131.

Copyright © 2016, Thrita. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Bhatnagar P, Desai E, Patel U, Leuva B. Delayed re-laparotomy after total hysterectomy. Int J Reprod Contracept Obstet Gynecol. 2013; 2(1): 12-5
  • 2. Hosseini M, Masoumi Kashani N. Assessment serum LH, FSH/tumor fluid FSH, LH ratio in ovarian mass. Pejouhesh. 2010; 34(3): 182-6
  • 3. Runnebaum IB, Stickeler E. Epidemiological and molecular aspects of ovarian cancer risk. J Cancer Res Clin Oncol. 2001; 127(2): 73-9[DOI]
  • 4. McGowan L. Ovarian cancer after hysterectomy. Obstet Gynecol. 1987; 69(3 Pt 1): 386-9[PubMed]
  • 5. Loft A, Lidegaard O, Tabor A. Incidence of ovarian cancer after hysterectomy: a nationwide controlled follow up. BJOG. 1997; 104(11): 1296-301[DOI]
  • 6. Holub Z, Jandourek M, Jabor A, Kliment L, Wagnerova M. Does hysterectomy without salpingo-oophorectomy influence the reoperation rate for adnexal pathology? A retrospective study. Clin Exp Obstet Gynecol. 1999; 27(2): 109-12
  • 7. Plockinger B, Kolbl H. Development of ovarian pathology after hysterectomy without oophorectomy. J Am Coll Surg. 1994; 178(6): 581-5[PubMed]
  • 8. Chan JK, Urban R, Capra AM, Jacoby V, Osann K, Whittemore A, et al. Ovarian cancer rates after hysterectomy with and without salpingo-oophorectomy. Obstet Gynecol. 2014; 123(1): 65-72[DOI][PubMed]
  • 9. Chiu Y, Chen C, Chiu L, Yen Y, Chang C, Tzeng C, et al. Occurrence of ovarian cancer 13 years after a total hysterectomy and bilateral salpingo-oophorectomy for endometriosis: A case report and literature review. GMIT. 2015; 4(1): 23-5[DOI]
  • 10. Vorwergk J, Radosa MP, Nicolaus K, Baus N, Jimenez Cruz J, Rengsberger M, et al. Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: Complications and re-operation rate. J Cancer Res Clin Oncol. 2014; 140(5): 859-65[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments